ArchivesMagazine - 15 Nov 2018Which small cap pharma firms make a profit? We explore the profitable companies in this notoriously high risk part of the market 15 November 2018|Feature|by Lisa-Marie Janes Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < Could logistics firms benefit from stockpiling ahead of Brexit? Turn patience into profit > Issue: 15 Nov 2018 - Page 40 | Contents Next: Turn patience into profit Previous: Could logistics firms benefit from stockpiling ahead of Brexit? Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Lisa-Marie Janes Issue Contents Ask Tom ‘How does pension tax relief work?’ Editor's View Are we entering a bear market and does it matter? Feature Could logistics firms benefit from stockpiling ahead of Brexit? Turn patience into profit Which small cap pharma firms make a profit? Funds Blue Whale goes straight to the top end of the fund chart Find out how ETFs are getting active Great Ideas Time to load up on AstraZeneca for capital gains and dividends Why we think National Grid is a firm buy for the future Experian continues to tick the right boxes On The Beach hit by sector woes Investment Trusts Can retail investors bag a unicorn? Do capital preservation funds perform as planned? News UK economic outlook flags risks for banks and consumer-facing businesses Dividend relief lifts Vodafone Are investors overreacting to talk of a possible US ban on menthol cigarettes? Supermarket sales slow after summer surprise Tracsis rules out cash return as acquisition pipeline bulges Personal Finance How to save money when you’re investing Russ Mould Why Warren Buffett seems to be running scared of bonds
